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Olfactory Acuity in Chronic Migraine: a Cross-sectional Study
ABSTRACT:
Objective: To measure olfactory acuity in chronic migraine subjects, at baseline and on
migraine days, and compare to age and sex-matched controls.
Background: Olfactory impairment is common in neurological disorders. While smell
hypersensitivity has been established with chronic migraine, olfactory acuity has not been
well studied.
Methods: We recruited 50 subjects with chronic migraine from the Jefferson Headache
Center and 50 age and sex-matched controls. Using the University of Pennsylvania Smell
Identification Test (UPSIT), a validated test of olfaction, olfactory acuity was measured
at baseline and during a migraine for subjects, and compared to controls at baseline and at
home 2 weeks later. All subjects were additionally screened for odor sensitivity and
allodynia.
Results: The mean UPSIT score for migraine subjects was 34.5 on non-migraine days
and 34.7 on migraine days [mean difference = -0.4, 95% CI (-1.3, 0.6) p = 0.45]. Controls
had a mean of 35.9 and 36.1 for each test day [mean difference = -0.1, 95% CI (-0.9, 0.7)
p = 0.87]. On average, migraineurs performed worse than their matched control
counterparts in both test sittings [test 1: p = 0.047; test 2: p = 0.01]. The great majority of
subjects were allodynic (42/50) compared with only 9 of 50 controls, and the majority of
subjects (41/50) found more than 1 listed odor to be bothersome, compared with only
10/50 controls. On non-migraine days 18/48 chronic migraine subjects had abnormal
olfaction and on migraine days 14/42 had abnormal olfaction, compared with only 9/50
controls who had abnormal olfaction on their first UPSIT.
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Conclusions: While chronic migraine patients do not appear to have a significant change
in olfactory acuity between migrainous and non-migrainous periods, they do appear to be
more likely to have abnormal olfactory acuity at baseline compared to age and sexmatched controls.
INTRODUCTION:
Patients with chronic migraine (CM) often display significant disability, as well
hypersensitivity to specific stimuli such as light and sound.1 Hypersensitivity to sensory
stimuli such light and sound are both diagnostic features of migraine,2 but migraine
patients are also much more likely to be bothered by odors than other persons. In fact,
osmophobia may be a more specific symptom in differentiating migraine from other
headache disorders.3, 4 Discomfort due to olfactory stimuli is most prominent during acute
migraine, but may persist between attacks.5
Olfactory impairment is a common symptom of other neurologic disorders such as
schizophrenia and Parkinson’s disease. This may be related to damage of dopaminergic,
serotonergic and cholinergic systems.6, 7 It is possible that olfactory hypersensitivity in
CM patients is related to this dopaminergic dysfunction. While olfactory sensitivity has
been demonstrated in patients with migraine, olfactory acuity in episodic migraine
subjects in between attacks is similar to age and sex-matched controls with a standardized
testing of olfaction.8 This includes our previous study of olfaction using the University of
Pennsylvania Smell Identification Test (UPSIT).9 In these episodic migraine subjects,
olfactory acuity decreased in many patients during acute migraine and even after
successful acute treatment. Based on these results, we hypothesized that CM patients
would have greater olfactory deficits on both migraine days and less severe days.
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METHODS:
We recruited 50 patients from the Jefferson Headache Center clinic from June – August
2011 meeting criteria for CM ages 18-65 as defined by the International Classification of
Headache Disorders (ICHD-2R).10 As indicated by the diagnosis, subjects were required
to have at least 8 migraine days a month (or days with acute migraine medication use)
and at least 15 days a month of headache. Additionally, the subjects had to meet the
migraine criteria of having headaches accompanied by either nausea and/or vomiting or
both photophobia and phonophobia. We obtained formal approval for this study from the
Institutional Review Board at Thomas Jefferson University and all subjects and controls
provided informed consent. We excluded subjects or controls with a history of significant
headache trauma, nasal or sinus disease, and neurologic disorders such as Parkinson
disease, dementia or multiple sclerosis. We excluded patients regularly taking sedating
medications during acute attacks, such as opioids. Given that subjects had to take the
UPSIT on both more severe migraine days and non-migraine days, we included patients
with some fluctuation between migraine and non-migraine days. Subjects who met the
inclusion criteria completed a questionnaire to determine disease diagnosis and history,
attain demographic information, and verify medications. No particular education level
was obtained. We used the questionnaire to determine the patients’ subjective olfactory
characteristics, asking subjects how they would describe their smell function during a
migraine day using the forced answers “improves”, “stays the same”, or “gets worse”.
We asked patients if they found one or more odors bothersome using a forced answer
question bank, recording the patient as being sensitive to odors if they answered “most
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always” or “always” for any of the odors presented. We established the presence of
allodynia during migraine using a validated questionnaire which screens for the presence
of unpleasant sensations of skin in response to routine activities such as combing hair,
wearing clothes or heat and cold exposure.11
After completing the questionnaire, subjects and controls took the UPSIT, a standardized,
validated test for olfaction.12 The test involves 40 odorants embedded in “scratch and
sniff” microcapsules, each with a four answer forced choice question about the identity of
the odorant. A score of 35 or greater is considered normal for women, and a score of 34
or greater is considered normal in men.12 A change in UPSIT score of greater than 3
points is considered clinically significant for the purposes of this study. Subjects were
then given a second UPSIT test to take home with them, to be taken 2 weeks later during
a migraine at home. If a subject took the UPSIT on the initial visit during a migraine
attack, they were required to repeat the UPSIT during a non-migraine day at least 2
weeks after the initial visit. The subjects were asked to take the non-migraine day test on
a day when they were completely free of any symptoms of their migraines or headaches,
and the timing of this was left to the determination of the subject. Subjects were required
to mail or drop off the second test at the Jefferson Headache Center.
For comparison, 50 controls were recruited from the hospital, community, and friends
and family of patients. Controls were age (± 2 years) and sex-matched and had no history
of migraine. Controls were excluded if they displayed any disability from headache as
determined by score of greater than “0” on the Migraine Disability Assessment (MIDAS)
Questionnaire.13 Controls completed a similar questionnaire as given to the subjects about
olfactory sensitivity, function and allodynia, and then completed an UPSIT test in the
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Jefferson Headache Center. Controls were then given an additional UPSIT test, which
they completed at home 2 weeks later and sent back to the clinic.
Statistical Analysis:
Baseline characteristics were compared between matched pairs of subjects and controls
using McNemar's or Bowker's tests of symmetry for categorical data, as appropriate, and
paired t-tests for continuous data. Similarly, paired t-tests were used to compare matched
subject and controls scores and scores from between test sittings. All tests are two-tailed
with statistical significance set at α = 0.05. Analyses were performed in SAS 9.3 (SAS
Institute Inc., Cary, NC).
The number of subjects was determined before the study based on previous studies using
UPSIT in various neurological disorders which assumed an effect size of 3 points for the
parameter of group differences in olfaction, and based on the funding available for this
study.
RESULTS:
We recruited 50 CM subjects and age and sex-matched controls, although one of the 10
male cases, a 43 year-old, was matched to a 42 year-old female control. CM subjects had
a mean age of 42 with a range of 18-63, while controls had a mean age of 41.7 with a
range of 20-64. The great majority of subjects were allodynic (42/50) compared with only
9 of 50 controls, and the majority of subjects (41/50) found more than 1 listed odor to be
bothersome, compared with only 10/50 controls. Table 1 lists demographic features of the
two groups. A majority (28/50) of subjects had aura, but 22/50 did not. Visual aura was
the most common type. Twenty-two subjects predicted increased olfactory acuity during
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migraine days, while only 4 predicted decreased olfaction and the remainder anticipated
no change or did not respond.
All controls and 48/50 subjects took the UPSIT at the initial visit. Forty of the 50 CM
subjects completed the UPSIT twice as did 47/50 controls. The mean UPSIT score for
migraine subjects was 34.5 on non-migraine days and 34.7 on migraine days [mean
difference = -0.4, 95% CI (-1.3, 0.6) p = 0.45]. Controls had a mean of 35.9 and 36.1 for
each test day [mean difference = -0.1, 95% CI (-0.9, 0.7) p = 0.87]. On average,
migraineurs performed slightly worse than their matched control counterparts in both test
sittings [test 1: mean difference = -1.5 (-3.0, 0.0) p = 0.047; test 2: mean difference = -1.5
(-2.7, -0.3) p = 0.01]. On non-migraine days 18/48 CM subjects had abnormal olfaction
and on migraine days 14/42 had abnormal olfaction (McNemar’s test, p = 1.00). Nine of
50 controls had abnormal olfaction on the first UPSIT, and 10 of 47 had abnormal scores
on follow-up testing. Four CM subjects had a decrease of olfaction of greater than 3
points on migraine compared to non-migraine days, while two had a greater than 3 point
increase in UPSIT scores on migraine days. Two controls had a decreased UPSIT score
of greater than 3 points on the second test and one had an increase of greater than 5
points. (Table 2) Of the 8 non-allodynic subjects with CM, 1 had abnormal olfaction and
1 did not complete the during-migraine UPSIT.
CONCLUSION:
Olfaction and sensitivity to odors is a significant problem in migraine, but olfactory
acuity is generally normal in persons with episodic migraine. However, there is
increasing evidence that for some persons olfactory acuity is affected by migraine. Hirsh,
in a study predating existing migraine classification, found that about 18% of migraine
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subjects were hyposmic or anosmic based on Pyridine odor threshold testing.14 Although
our previously described study found that persons with episodic migraine had normal
olfaction, a significant number had decreased olfaction during acute attacks.9 In this study
of CM subjects, a much larger proportion had abnormal olfaction but interestingly the
difference between migraine and non-migraine days was not significant.
When considering a change of greater than 3 points to be statistically significant, 4
patients with CM had significantly lower scores during migraine, and 2 had improved
scores. In CM subjects, their olfactory acuity does not appear to change on migraine days
of increased severity. This lack of change in olfaction suggests a more ingrained problem,
and may correlate with central sensitization. The majority of CM subjects in this study
had allodynia (42/50, 84%) but no patient without allodynia had abnormal olfaction. This
suggests poor olfaction could be a relatively specific measure for central sensitization in
migraine, much like in degenerative diseases.
Increases in parasympathetic tone, which can manifest as tearing, swelling or congestion
during migraine, is associated with engorgement of nasal turbinates.15 Fluctuations in
nasal engorgement are an overall indicator of autonomic tone16 and correlate with
measures such as rapid-eye movement sleep patterns17 and cognitive abilities18. It is
possible that CM produces these changes in autonomic tone, resulting in decreased ability
of odorants to successfully reach smell receptors, which would have negatively affected
performance on the UPSIT.
Abnormal olfaction in CM could be related to the known phenomenon of olfactory
distortions19 related to migraine. Functional neuroimaging data in chronic pain states that
demonstrate changes in activation of basal ganglia structures with loss of dopaminergic
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input and decreased connectivity to the prefrontal cortex20. This relates to another
interesting issue, which is each patient’s personal sense of olfactory acuity during acute
migraine days in CM. Among CM subjects a significant minority (22/50, 44%) reported
improved olfaction on migraine days, while only 2 patients (8%) felt their sense of smell
worsened and the majority reported no change (26/50, 52%). In our patients with episodic
migraine, subjects who reported improvement in olfactory acuity during migraine did not
actually improve. In CM subjects the results were mixed with 10 patients correctly
predicting improved olfaction and 7 with lower scores during migraine. This difference
was not statistically significant but was a contrast with our episodic migraine group.
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Table 1. Descriptive summary of group characteristics.

Age, mean (range)

Migraineurs

Controls

(n = 50)

(n = 50)

p

42.0 (18-63)

41.7 (20-64)

0.16

Sex, n (%)

0.32

Female

40

(80.0)

41

(82.0)

Male

10

(20.0)

9

(18.0)
0.90

Race, n (%)
White

46

(92.0)

41

(82.0)

Black

1

(2.0)

3

(6.0)

Asian

1

(2.0)

3

(6.0)

Hispanic

2

(4.0)

3

(6.0)

Height (in inches), mean + std

66.0 + 3.85

66.0 + 4.00

0.97

Weight (in lbs), mean + std

163 + 34.9

175 + 45.3

1.00

BMI, mean + std

26.3 + 4.74

28.3 + 7.78

0.13

Allodynia, n (%)

<0.01

Yes

42

(84.0)

9

(18.0)

No

8

(16.0)

41

(82.0)

Odors Bothersome, n (%)

Migraineurs

Controls

(n = 50)

(n = 50)

p
<0.01

12

Yes

41

(82.0)

10

(20.0)

No

9

(18.0)

40

(80.0)
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Table 2. Olfaction summary of outcomes
Paired
Difference
(MigraineMigraineurs

Controls

Control)

(n = 50)

(n= 50)

Mean (95% CI)

mean

34.5

35.9

-1.5 (-3.0, 0.0)

Abnormal, %

18/48, (37.5%)

9/50, (18.0%)

p = 0.047

mean

34.7

36.1

-1.5 (-2.7, -0.3)

abnormal, %

14/42, (33.3%)

10/47, (21.3%)

p = 0.01

Test Difference (2nd - 1st)

-0.4 (-1.3, 0.6)

-0.1 (-0.9, 0.7)

Mean (95% CI)

p = 0.45

p = 0.87

Non-migraine day (CM)
or baseline (control) score

Migraine Day or 2nd
UPSIT Score
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